Figure 3.
Pharmacokinetics of lenalidomide treatment. (A) Minimum lenalidomide plasma levels for the 30-mg once-daily dose group. (B) Minimum lenalidomide plasma levels in the 15-mg twice-daily dose group. Lenalidomide (CC-5013): mean ± SE.
Pharmacokinetics of lenalidomide treatment. (A) Minimum lenalidomide plasma levels for the 30-mg once-daily dose group. (B) Minimum lenalidomide plasma levels in the 15-mg twice-daily dose group. Lenalidomide (CC-5013): mean ± SE.
